{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:46:05Z","timestamp":1780551965799,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ovid Therapeutics Inc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11136-023-03375-4","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T11:02:51Z","timestamp":1681210971000},"page":"2059-2067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Health-related quality of life and medication use among individuals with Angelman syndrome"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-0503","authenticated-orcid":false,"given":"Nasreen","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Cabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca D.","family":"Burdine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hann","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Keary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Ochoa-Lubinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the STARS Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"issue":"5","key":"3375_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2006","unstructured":"Williams, C. A., Beaudet, A. L., Clayton-Smith, J., Knoll, J. H., Kyllerman, M., Laan, L. A., Magenis, R. E., Moncla, A., Schinzel, A. A., Summers, J. A., & Wagstaff, J. (2006). Angelman syndrome 2005: updated consensus for diagnostic criteria. American Journal of Medical Genetics Part A, 140(5), 413\u20138.","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"1","key":"3375_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ajmg.a.61382","volume":"182","author":"KG Bindels-de Heus","year":"2020","unstructured":"Bindels-de Heus, K. G., Mous, S. E., ten Hooven-Radstaake, M., van Iperen-Kolk, B. M., Navis, C., Rietman, A. B., Ten Hoopen, L. W., Brooks, A. S., ENCORE Expertise Center for AS, Elgersma, Y., & Moll, H. A. (2020). An overview of health issues and development in a large clinical cohort of children with Angelman syndrome. American Journal of Medical Genetics Part A, 182(1), 53\u201363.","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"10","key":"3375_CR3","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrneurol.2016.133","volume":"12","author":"K Buiting","year":"2016","unstructured":"Buiting, K., Williams, C., & Horsthemke, B. (2016). Angelman syndrome - insights into a rare neurogenetic disorder. Nature Reviews. Neurology, 12(10), 584\u2013593.","journal-title":"Nature Reviews. Neurology"},{"key":"3375_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/TACG.S57386","volume":"7","author":"LM Bird","year":"2014","unstructured":"Bird, L. M. (2014). Angelman syndrome: Review of clinical and molecular aspects. The Application of Clinical Genetics, 7, 93\u2013104.","journal-title":"The Application of Clinical Genetics"},{"issue":"10","key":"3375_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2165\/00148581-200305100-00001","volume":"5","author":"R Guerrini","year":"2003","unstructured":"Guerrini, R., Carrozzo, R., Rinaldi, R., & Bonanni, P. (2003). Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms. Paediatric Drugs, 5(10), 647\u2013661.","journal-title":"Paediatric Drugs"},{"issue":"4","key":"3375_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/ajmg.c.31536","volume":"172","author":"WH Tan","year":"2016","unstructured":"Tan, W. H., & Bird, L. M. (2016). Angelman syndrome: Current and emerging therapies in 2016. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 172(4), 384\u2013401.","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"key":"3375_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13023-017-0716-z","volume":"12","author":"AC Wheeler","year":"2017","unstructured":"Wheeler, A. C., Sacco, P., & Cabo, R. (2017). Unmet clinical needs and burden in Angelman syndrome: A review of the literature. Orphanet Journal of Rare Diseases, 12, 164.","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7","key":"3375_CR8","doi-asserted-by":"publisher","first-page":"e00734","DOI":"10.1002\/mgg3.734","volume":"7","author":"N Khan","year":"2019","unstructured":"Khan, N., Cabo, R., Tan, W. H., Tayag, R., & Bird, L. M. (2019). Healthcare burden among individuals with Angelman syndrome: Findings from the Angelman syndrome natural history study. Molecular Genetics & Genomic Medicine, 7(7), e00734.","journal-title":"Molecular Genetics & Genomic Medicine"},{"issue":"4","key":"3375_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2788.2011.01386.x","volume":"55","author":"GM Griffith","year":"2011","unstructured":"Griffith, G. M., Hastings, R. P., Oliver, C., Howlin, P., Moss, J., Petty, J., & Tunnicliffe, P. (2011). Psychological well-being in parents of children with Angelman, Cornelia de Lange and Cri du Chat syndromes. Journal of Intellectual Disability Research, 55(4), 397\u2013410.","journal-title":"Journal of Intellectual Disability Research"},{"key":"3375_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10578-020-01051-z","author":"T Willgoss","year":"2021","unstructured":"Willgoss, T., Cassater, D., Connor, S., Krishnan, M. L., Miller, M. T., Dias-Barbosa, C., Phillips, D., McCormack, J., Bird, L. M., Burdine, R. D., & Claridge, S. (2021). Measuring what matters to individuals with Angelman syndrome and their families: development of a patient-centered disease concept model. Child Psychiatry & Human Development. https:\/\/doi.org\/10.1007\/s10578-020-01051-z","journal-title":"Child Psychiatry & Human Development"},{"issue":"2","key":"3375_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ajmg.a.36864","volume":"167A","author":"AM Larson","year":"2015","unstructured":"Larson, A. M., Shinnick, J. E., Shaaya, E. A., Thiele, E. A., & Thibert, R. L. (2015). Angelman syndrome in adulthood. American Journal of Medical Genetics Part A, 167A(2), 331\u2013344.","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"3","key":"3375_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1352\/1944-7558-123.3.241","volume":"123","author":"D Adams","year":"2018","unstructured":"Adams, D., Clarke, S., Griffith, G., Howlin, P., Moss, J., Petty, J., Tunnicliffe, P., & Oliver, C. (2018). Mental health and well-being in mothers of children with rare genetic syndromes showing chronic challenging behavior: A cross-sectional and longitudinal study. American Journal on Intellectual and Developmental Disabilities, 123(3), 241\u2013253.","journal-title":"American Journal on Intellectual and Developmental Disabilities"},{"issue":"1","key":"3375_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40271-018-0323-7","volume":"12","author":"JC Grieco","year":"2019","unstructured":"Grieco, J. C., Romero, B., Flood, E., Cabo, R., & Visootsak, J. (2019). Conceptual model of Angelman syndrome and review of relevant clinical outcomes assessments (COAs). Patient, 12(1), 97\u2013112.","journal-title":"Patient"},{"key":"3375_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13023-019-1210-6","volume":"14","author":"N Khan","year":"2019","unstructured":"Khan, N., Cabo, R., Tan, W. H., Tayag, R., & Bird, L. M. (2019). An observational study of pediatric healthcare burden in Angelman syndrome: results from a real-world study. Orphanet Journal of Rare Diseases, 14, 239.","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"5","key":"3375_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/09638280500190631","volume":"28","author":"AK Thomson","year":"2006","unstructured":"Thomson, A. K., Glasson, E. J., & Bittles, A. H. (2006). A long-term population-based clinical and morbidity profile of Angelman syndrome in Western Australia: 1953\u20132003. Disability and Rehabilitation, 28(5), 299\u2013305.","journal-title":"Disability and Rehabilitation"},{"issue":"3","key":"3375_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/jar.12411","volume":"31","author":"MF Dom\u00ednguez-Berj\u00f3n","year":"2018","unstructured":"Dom\u00ednguez-Berj\u00f3n, M. F., Zoni, A. C., Esteban-Vasallo, M. D., Sendra-Guti\u00e9rrez, J. M., & Astray-Mochales, J. (2018). Main causes of hospitalization in people with Angelman syndrome. Journal of Applied Research in Intellectual Disabilities, 31(3), 466\u2013469.","journal-title":"Journal of Applied Research in Intellectual Disabilities"},{"key":"3375_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000011409","author":"LM Bird","year":"2021","unstructured":"Bird, L. M., Ochoa-Lubinoff, C., Tan, W. H., Heimer, G., Melmed, R. D., Rakhit, A., Visootsak, J., During, M. J., Holcroft, C., Burdine, R. D., & Kolevzon, A. (2021). The stars phase 2 study: A randomized controlled trial of gaboxadol in Angelman syndrome. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000011409","journal-title":"Neurology"},{"issue":"10","key":"3375_CR18","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M., Gudex, C., Lloyd, A., Janssen, M. F., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727\u201336.","journal-title":"Quality of Life Research"},{"issue":"11","key":"3375_CR19","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095\u20131108.","journal-title":"Medical Care"},{"issue":"8","key":"3375_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jval.2019.02.009","volume":"22","author":"AS Pickard","year":"2019","unstructured":"Pickard, A. S., Law, E. H., Jiang, R., Pullenayegum, E., Shaw, J. W., Xie, F., Oppe, M., Boye, K. S., Chapman, R. H., Gong, C. L., & Balch, A. (2019). United States valuation of EQ-5D-5L health states using an international protocol. Value in Health, 22(8), 931\u2013941.","journal-title":"Value in Health"},{"issue":"3","key":"3375_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203\u2013220.","journal-title":"Medical Care"},{"issue":"3","key":"3375_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"G Euroquol","year":"1990","unstructured":"Euroquol, G. (1990). EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy, 16(3), 199\u2013208.","journal-title":"Health Policy"},{"key":"3375_CR23","volume-title":"Self-Reported Population Health: An International Perspective based on EQ-5D, in Self-Reported Population Health: An International Perspective based on EQ-5D","author":"B Janssen","year":"2014","unstructured":"Janssen, B., & Szende, A. (2014). Population Norms for the EQ-5D. Self-Reported Population Health: An International Perspective based on EQ-5D, in Self-Reported Population Health: An International Perspective based on EQ-5D. Springer."},{"issue":"3","key":"3375_CR24","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11136-020-02650-y","volume":"30","author":"R Jiang","year":"2021","unstructured":"Jiang, R., Janssen, M. F. B., & Pickard, A. S. (2021). US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples. Quality of Life Research, 30(3), 803\u2013816.","journal-title":"Quality of Life Research"},{"issue":"Suppl 1","key":"3375_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10198-016-0784-3","volume":"17","author":"K Chevreul","year":"2016","unstructured":"Chevreul, K., Gandr\u00e9, C., Brigham, K. B., L\u00f3pez-Bastida, J., Linertov\u00e1, R., Oliva-Moreno, J., Serrano-Aguilar, P., Posada-de-la-Paz, M., Taruscio, D., Schieppati, A., & Iskrov, G. (2016). Social\/economic costs and health-related quality of life in patients with fragile X syndrome in Europe. The European Journal of Health Economics, 17(Suppl 1), 43\u201352.","journal-title":"The European Journal of Health Economics"},{"issue":"Suppl 1","key":"3375_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10198-016-0782-5","volume":"17","author":"M Cavazza","year":"2016","unstructured":"Cavazza, M., et al. (2016). Social\/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. The European Journal of Health Economics, 17(Suppl 1), 19\u201329.","journal-title":"The European Journal of Health Economics"},{"issue":"8","key":"3375_CR27","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s10198-022-01435-z","volume":"23","author":"J Lin","year":"2022","unstructured":"Lin, J., Wong, C. K. H., Cheung, J. P. Y., Cheung, P. W. H., & Luo, N. (2022). Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis. The European Journal of Health Economics, 23(8), 1383\u201395.","journal-title":"The European Journal of Health Economics"},{"issue":"2","key":"3375_CR28","doi-asserted-by":"publisher","first-page":"e048232","DOI":"10.1136\/bmjopen-2020-048232","volume":"12","author":"T Takura","year":"2022","unstructured":"Takura, T., Koike, T., Matsuo, Y., Sekimoto, A., & Mutou, M. (2022). Proxy responses regarding quality of life of patients with terminal lung cancer: preliminary results from a prospective observational study. BMJ Open, 12(2), e048232.","journal-title":"BMJ Open"},{"issue":"4","key":"3375_CR29","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/ageing\/afab053","volume":"50","author":"C Kelly","year":"2021","unstructured":"Kelly, C., Hulme, C., Graham, L., Ellwood, A., Patel, I., Cundill, B., Farrin, A., Goodwin, M., Hull, K., Fisher, J., & Forster, A. (2021). Inter-rater reliability of care home staff\u2019s proxy judgements with residents\u2019 assessments of their own health-related quality of life: an analysis of the PATCH trial EQ-5D data. Age Ageing, 50(4), 1314\u20131320.","journal-title":"Age Ageing"},{"issue":"1","key":"3375_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12955-022-01996-w","volume":"20","author":"TS Fitriana","year":"2022","unstructured":"Fitriana, T. S., Purba, F. D., Stolk, E., & Busschbach, J. J. (2022). EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report. Health and Quality of Life Outcomes, 20(1), 88.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"11","key":"3375_CR31","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1016\/j.ridd.2013.09.009","volume":"34","author":"G Balboni","year":"2013","unstructured":"Balboni, G., Coscarelli, A., Giunti, G., & Schalock, R. L. (2013). The assessment of the quality of life of adults with intellectual disability: The use of self-report and report of others assessment strategies. Research in Developmental Disabilities., 34(11), 4248\u20134254.","journal-title":"Research in Developmental Disabilities."},{"issue":"2","key":"3375_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/dmcn.14301","volume":"62","author":"R Lamsal","year":"2020","unstructured":"Lamsal, R., Finlay, B., Whitehurst, D. G., & Zwicker, J. D. (2020). Generic preference-based health-related quality of life in children with neurodevelopmental disorders: a scoping review. Developmental Medicine & Child Neurology, 62(2), 169\u2013177.","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"Suppl 1","key":"3375_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10198-016-0787-0","volume":"17","author":"M P\u00e9ntek","year":"2016","unstructured":"P\u00e9ntek, M., Gul\u00e1csi, L., Brodszky, V., Baji, P., Boncz, I., Pog\u00e1ny, G., L\u00f3pez-Bastida, J., Linertov\u00e1, R., Oliva-Moreno, J., Serrano-Aguilar, P., & Posada-de-la-Paz, M. (2016). Social\/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe. The European Journal of Health Economics, 17(Suppl 1), 89\u201398.","journal-title":"The European Journal of Health Economics"},{"issue":"Suppl 1","key":"3375_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10198-016-0788-z","volume":"17","author":"J L\u00f3pez-Bastida","year":"2016","unstructured":"L\u00f3pez-Bastida, J., Linertov\u00e1, R., Oliva-Moreno, J., Posada-de-la-Paz, M., Serrano-Aguilar, P., Kanavos, P., Taruscio, D., Schieppati, A., Iskrov, G., Baji, P., & Delgado, C. (2016). Social\/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe. The European Journal of Health Economics, 17(Suppl 1), 99\u2013108.","journal-title":"The European Journal of Health Economics"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-023-03375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-023-03375-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-023-03375-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T11:24:15Z","timestamp":1685964255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-023-03375-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1007\/s11136-023-03375-4","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"assertion":[{"value":"12 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Khan is a paid consultant for Ovid Therapeutics. Ms. Cabo is an employee of Ovid Therapeutics. Dr. Burdine consults on clinical trials supported by Ovid Therapeutics. Dr. Tan has participated in clinical trials supported by Ovid Therapeutics and Dimension Therapeutics and has also received research support from Ovid Therapeutics. Dr. Keary has consulted for Ovid Therapeutics and is participating in clinical trials supported by Ovid Therapeutics. Dr. Ochoa-Lubinoff has consulted for Ovid Therapeutics and participated in clinical trials supported by Ovid Therapeutics. Dr. Bird is participating in clinical trials supported by Ovid Therapeutics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Protocol approval and ethics oversight was provided by the regional IRBs\/ECs at each site. Written informed consent was obtained from the legally authorized representative of each participating individual, prior to any study procedures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}